Sign in to edit your profile (add interests, mentoring, photo, etc.)

    Yuet Kan, MD

    TitleProfessor
    SchoolUCSF School of Medicine
    DepartmentMedicine
    Address513 Parnassus Ave
    San Francisco CA 94143
    Phone415-476-5841

       Overview 
       Overview
      Research Interests: The mechanisms of globin production and exploring novel ways of inserting genes into mammalian cells; investigating newer approaches for fetal diagnosis of genetic disorders.

      Research Summary: The research in our laboratory is focused on the study of two inherited blood diseases; sickle cell anemia and thalassemia. These two diseases constitute the most common genetic diseases in the world and they affect people of African, Mediterranean, Middle East, and Asian origins. At present, treatment mostly consists of treatment of symptoms and complications. Bone marrow or cord blood transfusion can be curative when compatible donors can be found. However, since most of these families have a small number of children, only a minority of patients can be treated by transplantation.

      An effective way of preventing genetic diseases such as sickle cell anemia and thalassemia is by carrier screening, genetic counseling, and prenatal diagnosis. Our laboratory has been involved in prenatal diagnosis from the 1970s. Currently, amniocentesis and chorionic villus sampling is used to obtain DNA for diagnosis. We are investigating the isolation of fetal cells from the mother’s blood for testing so that an invasive procedure to the fetus can be avoided.
      Out laboratory is also investigating gene and cell therapy for treating these conditions. In a thalassemia, the affected fetus usually dies in the third trimester or soon after birth. We have explored in utero gene therapy to treat this condition. Using a mouse model of alpha thalassemia that we have previously made, we introduced to the mouse embryo at the 14th day of gestation a lentiviral vector that contained the human alpha globin gene. Preliminary studies showed that human alpha globin was expressed at moderately levels. Our plan is to see if these vectors can rescue the fetal mouse affected by homozygous a thalassemia.

      The mutations in sickle cell anemia and most clinically important ß thalassemia lie in the ß globin gene. Therefore, the approach to stem cell therapy for both is similar. We first tested embryonic stem cell therapy for a mouse model of sickle cell anemia. We made embryonic stem cells from a sickle cell anemia mouse, corrected the mutation by homologous recombination, differentiated the stem cells into hematopoietic cells and showed that the blood cells made hemoglobin A in additional to hemoglobin S.

      To apply this treatment for the human diseases, it will be necessary to use nuclear transfer in stem cells in order to avoid immunological rejection. However, nuclear transfer to make embryonic stem cell has not been successful in humans. Also, the procedure is complicated, requires egg donors from normal individuals and raises ethical concern. With the description of induced pluripotent stem (iPS) cells, we have now changed to this approach for the treatment of these conditions. Our laboratory has successfully made iPS cells from mouse and human fibroblasts by retroviral delivery of transcription vectors.

      Currently, we are working on correcting mutation in these iPS cells and differentiate them into hematopoietic cells. The future goal to treatment is to take skin cells from patients, differentiate them into iPS cells, correct the mutations by homologous recombination, and differentiate into the hematopoietic cells and re-infuse them into the patients. Since the cells originate from the patients, there would not be immuno-rejection. In order to achieve this goal, several conditions must first be met. First, to convert the skin cell into IPs cell it is necessary to use retrovirus induction. However, integration of retrovirus may disturb vital gene functions. Second, a reliable way of differentiating iPS cells into hematopoietic cells has to be established. We feel strongly that this approach will provide a means for curing these diseases.


       ORNG Applications 
       Websites
       In The News
       Awarded Grants
       More Info

       Bibliographic 
       Publications
      Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help.
      List All   |   Timeline
      1. Xie F, Ye L, Chang JC, Beyer AI, Wang J, Muench MO, Kan YW. Seamless gene correction of ß-thalassemia mutations in patient-specific iPSCs using CRISPR/Cas9 and piggyBac. Genome Res. 2014 Sep; 24(9):1526-33.
        View in: PubMed
      2. Ye L, Wang J, Beyer AI, Teque F, Cradick TJ, Qi Z, Chang JC, Bao G, Muench MO, Yu J, Levy JA, Kan YW. Seamless modification of wild-type induced pluripotent stem cells to the natural CCR5?32 mutation confers resistance to HIV infection. Proc Natl Acad Sci U S A. 2014 Jun 9.
        View in: PubMed
      3. Ye L, Muench MO, Fusaki N, Beyer AI, Wang J, Qi Z, Yu J, Kan YW. Blood cell-derived induced pluripotent stem cells free of reprogramming factors generated by Sendai viral vectors. Stem Cells Transl Med. 2013 Aug; 2(8):558-66.
        View in: PubMed
      4. Cao A, Kan YW. The prevention of thalassemia. Cold Spring Harb Perspect Med. 2013 Feb; 3(2):a011775.
        View in: PubMed
      5. Tao Z, Chen B, Tan X, Zhao Y, Wang L, Zhu T, Cao K, Yang Z, Kan YW, Su H. Coexpression of VEGF and angiopoietin-1 promotes angiogenesis and cardiomyocyte proliferation reduces apoptosis in porcine myocardial infarction (MI) heart. Proc Natl Acad Sci U S A. 2011 Feb 1; 108(5):2064-9.
        View in: PubMed
      6. Wruck CJ, Fragoulis A, Gurzynski A, Brandenburg LO, Kan YW, Chan K, Hassenpflug J, Freitag-Wolf S, Varoga D, Lippross S, Pufe T. Role of oxidative stress in rheumatoid arthritis: insights from the Nrf2-knockout mice. Ann Rheum Dis. 2011 May; 70(5):844-50.
        View in: PubMed
      7. Wruck CJ, Streetz K, Pavic G, Götz ME, Tohidnezhad M, Brandenburg LO, Varoga D, Eickelberg O, Herdegen T, Trautwein C, Cha K, Kan YW, Pufe T. Nrf2 induces interleukin-6 (IL-6) expression via an antioxidant response element within the IL-6 promoter. J Biol Chem. 2011 Feb 11; 286(6):4493-9.
        View in: PubMed
      8. Ye L, Chang JC, Lin C, Qi Z, Yu J, Kan YW. Generation of induced pluripotent stem cells using site-specific integration with phage integrase. Proc Natl Acad Sci U S A. 2010 Nov 9; 107(45):19467-72.
        View in: PubMed
      9. Kan YW, Chang JC. Molecular diagnosis of hemoglobinopathies and thalassemia. Prenat Diagn. 2010 Jul; 30(7):608-10.
        View in: PubMed
      10. Yu S, Khor TO, Cheung KL, Li W, Wu TY, Huang Y, Foster BA, Kan YW, Kong AN. Nrf2 expression is regulated by epigenetic mechanisms in prostate cancer of TRAMP mice. PLoS One. 2010; 5(1):e8579.
        View in: PubMed
      11. Liu B, Feng D, Lin G, Cao M, Kan YW, Cunha GR, Baskin LS. Signalling molecules involved in mouse bladder smooth muscle cellular differentiation. Int J Dev Biol. 2010; 54(1):175-80.
        View in: PubMed
      12. Pons J, Huang Y, Takagawa J, Arakawa-Hoyt J, Ye J, Grossman W, Kan YW, Su H. Combining angiogenic gene and stem cell therapies for myocardial infarction. J Gene Med. 2009 Sep; 11(9):743-53.
        View in: PubMed
      13. Ye L, Chang JC, Lin C, Sun X, Yu J, Kan YW. Induced pluripotent stem cells offer new approach to therapy in thalassemia and sickle cell anemia and option in prenatal diagnosis in genetic diseases. Proc Natl Acad Sci U S A. 2009 Jun 16; 106(24):9826-30.
        View in: PubMed
      14. Chen PC, Vargas MR, Pani AK, Smeyne RJ, Johnson DA, Kan YW, Johnson JA. Nrf2-mediated neuroprotection in the MPTP mouse model of Parkinson's disease: Critical role for the astrocyte. Proc Natl Acad Sci U S A. 2009 Feb 24; 106(8):2933-8.
        View in: PubMed
      15. Saeed M, Martin A, Jacquier A, Bucknor M, Saloner D, Do L, Ursell P, Su H, Kan YW, Higgins CB. Permanent coronary artery occlusion: cardiovascular MR imaging is platform for percutaneous transendocardial delivery and assessment of gene therapy in canine model. Radiology. 2008 Nov; 249(2):560-71.
        View in: PubMed
      16. Leung KM, Feng DX, Lou J, Zhou Y, Fung KP, Waye MM, Tsui SK, Chan PK, Marks JD, Pang SF, Kan YW. Development of human single-chain antibodies against SARS-associated coronavirus. Intervirology. 2008; 51(3):173-81.
        View in: PubMed
      17. Xu W, Hellerbrand C, Köhler UA, Bugnon P, Kan YW, Werner S, Beyer TA. The Nrf2 transcription factor protects from toxin-induced liver injury and fibrosis. Lab Invest. 2008 Oct; 88(10):1068-78.
        View in: PubMed
      18. Su H, Takagawa J, Huang Y, Arakawa-Hoyt J, Pons J, Grossman W, Kan YW. Additive effect of AAV-mediated angiopoietin-1 and VEGF expression on the therapy of infarcted heart. Int J Cardiol. 2009 Apr 3; 133(2):191-7.
        View in: PubMed
      19. Ye L, Chang JC, Lu R, Kan YW. High oxygen environment during pregnancy rescues sickle cell anemia mice from prenatal death. Blood Cells Mol Dis. 2008 Jul-Aug; 41(1):67-72.
        View in: PubMed
      20. Su H, Yeghiazarians Y, Lee A, Huang Y, Arakawa-Hoyt J, Ye J, Orcino G, Grossman W, Kan YW. AAV serotype 1 mediates more efficient gene transfer to pig myocardium than AAV serotype 2 and plasmid. J Gene Med. 2008 Jan; 10(1):33-41.
        View in: PubMed
      21. Beyer TA, Xu W, Teupser D, auf dem Keller U, Bugnon P, Hildt E, Thiery J, Kan YW, Werner S. Impaired liver regeneration in Nrf2 knockout mice: role of ROS-mediated insulin/IGF-1 resistance. EMBO J. 2008 Jan 9; 27(1):212-23.
        View in: PubMed
      22. Zhao X, Sun G, Zhang J, Strong R, Dash PK, Kan YW, Grotta JC, Aronowski J. Transcription factor Nrf2 protects the brain from damage produced by intracerebral hemorrhage. Stroke. 2007 Dec; 38(12):3280-6.
        View in: PubMed
      23. Han XD, Lin C, Chang J, Sadelain M, Kan YW. Fetal gene therapy of alpha-thalassemia in a mouse model. Proc Natl Acad Sci U S A. 2007 May 22; 104(21):9007-11.
        View in: PubMed
      24. Su H, Kan YW. Adeno-associated viral vector-delivered hypoxia-inducible gene expression in ischemic hearts. Methods Mol Biol. 2007; 366:331-42.
        View in: PubMed
      25. Shen F, Su H, Liu W, Kan YW, Young WL, Yang GY. Recombinant adeno-associated viral vector encoding human VEGF165 induces neomicrovessel formation in the adult mouse brain. Front Biosci. 2006; 11:3190-8.
        View in: PubMed
      26. Kraft AD, Lee JM, Johnson DA, Kan YW, Johnson JA. Neuronal sensitivity to kainic acid is dependent on the Nrf2-mediated actions of the antioxidant response element. J Neurochem. 2006 Sep; 98(6):1852-65.
        View in: PubMed
      27. Su H, Huang Y, Takagawa J, Barcena A, Arakawa-Hoyt J, Ye J, Grossman W, Kan YW. AAV serotype-1 mediates early onset of gene expression in mouse hearts and results in better therapeutic effect. Gene Ther. 2006 Nov; 13(21):1495-502.
        View in: PubMed
      28. Kan YW. Yuet Wai Kan, MD: sickle cell and thalassemia pioneer. Interview by Tracy Hampton. JAMA. 2006 Mar 1; 295(9):991.
        View in: PubMed
      29. Hu X, Roberts JR, Apopa PL, Kan YW, Ma Q. Accelerated ovarian failure induced by 4-vinyl cyclohexene diepoxide in Nrf2 null mice. Mol Cell Biol. 2006 Feb; 26(3):940-54.
        View in: PubMed
      30. Chang JC, Ye L, Kan YW. Correction of the sickle cell mutation in embryonic stem cells. Proc Natl Acad Sci U S A. 2006 Jan 24; 103(4):1036-40.
        View in: PubMed
      31. Feng D, Kan YW. The binding of the ubiquitous transcription factor Sp1 at the locus control region represses the expression of beta-like globin genes. Proc Natl Acad Sci U S A. 2005 Jul 12; 102(28):9896-900.
        View in: PubMed
      32. Calkins MJ, Jakel RJ, Johnson DA, Chan K, Kan YW, Johnson JA. Protection from mitochondrial complex II inhibition in vitro and in vivo by Nrf2-mediated transcription. Proc Natl Acad Sci U S A. 2005 Jan 4; 102(1):244-9.
        View in: PubMed
      33. Su H, Joho S, Huang Y, Barcena A, Arakawa-Hoyt J, Grossman W, Kan YW. Adeno-associated viral vector delivers cardiac-specific and hypoxia-inducible VEGF expression in ischemic mouse hearts. Proc Natl Acad Sci U S A. 2004 Nov 16; 101(46):16280-5.
        View in: PubMed
      34. Lee JM, Chan K, Kan YW, Johnson JA. Targeted disruption of Nrf2 causes regenerative immune-mediated hemolytic anemia. Proc Natl Acad Sci U S A. 2004 Jun 29; 101(26):9751-6.
        View in: PubMed
      35. Ma Q, Kinneer K, Bi Y, Chan JY, Kan YW. Induction of murine NAD(P)H:quinone oxidoreductase by 2,3,7,8-tetrachlorodibenzo-p-dioxin requires the CNC (cap 'n' collar) basic leucine zipper transcription factor Nrf2 (nuclear factor erythroid 2-related factor 2): cross-interaction between AhR (aryl hydrocarbon receptor) and Nrf2 signal transduction. Biochem J. 2004 Jan 1; 377(Pt 1):205-13.
        View in: PubMed
      36. Rogers RS, Graziottin TM, Lin CS, Kan YW, Lue TF. Intracavernosal vascular endothelial growth factor (VEGF) injection and adeno-associated virus-mediated VEGF gene therapy prevent and reverse venogenic erectile dysfunction in rats. Int J Impot Res. 2003 Feb; 15(1):26-37.
        View in: PubMed
      37. Lee JM, Calkins MJ, Chan K, Kan YW, Johnson JA. Identification of the NF-E2-related factor-2-dependent genes conferring protection against oxidative stress in primary cortical astrocytes using oligonucleotide microarray analysis. J Biol Chem. 2003 Apr 4; 278(14):12029-38.
        View in: PubMed
      38. Chang DS, Su H, Tang GL, Brevetti LS, Sarkar R, Wang R, Kan YW, Messina LM. Adeno-associated viral vector-mediated gene transfer of VEGF normalizes skeletal muscle oxygen tension and induces arteriogenesis in ischemic rat hindlimb. Mol Ther. 2003 Jan; 7(1):44-51.
        View in: PubMed
      39. Marini MG, Asunis I, Chan K, Chan JY, Kan YW, Porcu L, Cao A, Moi P. Cloning MafF by recognition site screening with the NFE2 tandem repeat of HS2: analysis of its role in globin and GCSl genes regulation. Blood Cells Mol Dis. 2002 Sep-Oct; 29(2):145-58.
        View in: PubMed
      40. Braun S, Hanselmann C, Gassmann MG, auf dem Keller U, Born-Berclaz C, Chan K, Kan YW, Werner S. Nrf2 transcription factor, a novel target of keratinocyte growth factor action which regulates gene expression and inflammation in the healing skin wound. Mol Cell Biol. 2002 Aug; 22(15):5492-505.
        View in: PubMed
      41. Su H, Arakawa-Hoyt J, Kan YW. Adeno-associated viral vector-mediated hypoxia response element-regulated gene expression in mouse ischemic heart model. Proc Natl Acad Sci U S A. 2002 Jul 9; 99(14):9480-5.
        View in: PubMed
      42. Bakircioglu ME, Lin CS, Fan P, Sievert KD, Kan YW, Lue TF. The effect of adeno-associated virus mediated brain derived neurotrophic factor in an animal model of neurogenic impotence. J Urol. 2001 Jun; 165(6 Pt 1):2103-9.
        View in: PubMed
      43. Ruan H, Su H, Hu L, Lamborn KR, Kan YW, Deen DF. A hypoxia-regulated adeno-associated virus vector for cancer-specific gene therapy. Neoplasia. 2001 May-Jun; 3(3):255-63.
        View in: PubMed
      44. Chan K, Han XD, Kan YW. An important function of Nrf2 in combating oxidative stress: detoxification of acetaminophen. Proc Natl Acad Sci U S A. 2001 Apr 10; 98(8):4611-6.
        View in: PubMed
      45. Huie MA, Cheung MC, Muench MO, Becerril B, Kan YW, Marks JD. Antibodies to human fetal erythroid cells from a nonimmune phage antibody library. Proc Natl Acad Sci U S A. 2001 Feb 27; 98(5):2682-7.
        View in: PubMed
      46. Mentzer WC, Kan YW. Prospects for research in hematologic disorders: sickle cell disease and thalassemia. JAMA. 2001 Feb 7; 285(5):640-2.
        View in: PubMed
      47. Su H, Lu R, Kan YW. Adeno-associated viral vector-mediated vascular endothelial growth factor gene transfer induces neovascular formation in ischemic heart. Proc Natl Acad Sci U S A. 2000 Dec 5; 97(25):13801-6.
        View in: PubMed
      48. Su H, Lu R, Ding R, Kan YW. Adeno-associated viral-mediated gene transfer to hepatoma: thymidine kinase/interleukin 2 is more effective in tumor killing in non-ganciclovir (GCV)-treated than in GCV-treated animals. Mol Ther. 2000 Jun; 1(6):509-15.
        View in: PubMed
      49. Yuan Q, Zhao F, Chung SW, Fan P, Sultzer BM, Kan YW, Wong PM. Dominant negative down-regulation of endotoxin-induced tumor necrosis factor alpha production by Lps(d)/Ran. Proc Natl Acad Sci U S A. 2000 Mar 14; 97(6):2852-7.
        View in: PubMed
      50. Kwong M, Kan YW, Chan JY. The CNC basic leucine zipper factor, Nrf1, is essential for cell survival in response to oxidative stress-inducing agents. Role for Nrf1 in gamma-gcs(l) and gss expression in mouse fibroblasts. J Biol Chem. 1999 Dec 24; 274(52):37491-8.
        View in: PubMed
      51. Chan K, Kan YW. Nrf2 is essential for protection against acute pulmonary injury in mice. Proc Natl Acad Sci U S A. 1999 Oct 26; 96(22):12731-6.
        View in: PubMed
      52. Wong PM, Kang A, Chen H, Yuan Q, Fan P, Sultzer BM, Kan YW, Chung SW. Lps(d)/Ran of endotoxin-resistant C3H/HeJ mice is defective in mediating lipopolysaccharide endotoxin responses. Proc Natl Acad Sci U S A. 1999 Sep 28; 96(20):11543-8.
        View in: PubMed
      53. Henderson PT, Jones D, Hampikian G, Kan Y, Schuster GB. Long-distance charge transport in duplex DNA: the phonon-assisted polaron-like hopping mechanism. Proc Natl Acad Sci U S A. 1999 Jul 20; 96(15):8353-8.
        View in: PubMed
      54. Chang JC, Lu R, Lin C, Xu SM, Kan YW, Porcu S, Carlson E, Kitamura M, Yang S, Flebbe-Rehwaldt L, Gaensler KM. Transgenic knockout mice exclusively expressing human hemoglobin S after transfer of a 240-kb betas-globin yeast artificial chromosome: A mouse model of sickle cell anemia. Proc Natl Acad Sci U S A. 1998 Dec 8; 95(25):14886-90.
        View in: PubMed
      55. Delgado M, Munoz-Elias EJ, Kan Y, Gozes I, Fridkin M, Brenneman DE, Gomariz RP, Ganea D. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit tumor necrosis factor alpha transcriptional activation by regulating nuclear factor-kB and cAMP response element-binding protein/c-Jun. J Biol Chem. 1998 Nov 20; 273(47):31427-36.
        View in: PubMed
      56. Ikuta T, Kan YW, Swerdlow PS, Faller DV, Perrine SP. Alterations in protein-DNA interactions in the gamma-globin gene promoter in response to butyrate therapy. Blood. 1998 Oct 15; 92(8):2924-33.
        View in: PubMed
      57. Chan V, Lau K, Yip B, Sin SY, Cheung MC, Kan YW. Diagnosis of spinal muscular atrophy from fetal normoblasts in maternal blood. Lancet. 1998 Oct 10; 352(9135):1196-8.
        View in: PubMed
      58. Zhang L, Wang D, Fischer H, Fan PD, Widdicombe JH, Kan YW, Dong JY. Efficient expression of CFTR function with adeno-associated virus vectors that carry shortened CFTR genes. Proc Natl Acad Sci U S A. 1998 Aug 18; 95(17):10158-63.
        View in: PubMed
      59. Chan JY, Kwong M, Lu R, Chang J, Wang B, Yen TS, Kan YW. Targeted disruption of the ubiquitous CNC-bZIP transcription factor, Nrf-1, results in anemia and embryonic lethality in mice. EMBO J. 1998 Mar 16; 17(6):1779-87.
        View in: PubMed
      60. Su H, Lu R, Chang JC, Kan YW. Tissue-specific expression of herpes simplex virus thymidine kinase gene delivered by adeno-associated virus inhibits the growth of human hepatocellular carcinoma in athymic mice. Proc Natl Acad Sci U S A. 1997 Dec 9; 94(25):13891-6.
        View in: PubMed
      61. Marini MG, Chan K, Casula L, Kan YW, Cao A, Moi P. hMAF, a small human transcription factor that heterodimerizes specifically with Nrf1 and Nrf2. J Biol Chem. 1997 Jun 27; 272(26):16490-7.
        View in: PubMed
      62. Chan K, Lu R, Chang JC, Kan YW. NRF2, a member of the NFE2 family of transcription factors, is not essential for murine erythropoiesis, growth, and development. Proc Natl Acad Sci U S A. 1996 Nov 26; 93(24):13943-8.
        View in: PubMed
      63. Cheung MC, Goldberg JD, Kan YW. Prenatal diagnosis of sickle cell anaemia and thalassaemia by analysis of fetal cells in maternal blood. Nat Genet. 1996 Nov; 14(3):264-8.
        View in: PubMed
      64. Chang J, Lu RH, Xu SM, Meneses J, Chan K, Pedersen R, Kan YW. Inactivation of mouse alpha-globin gene by homologous recombination: mouse model of hemoglobin H disease. Blood. 1996 Sep 1; 88(5):1846-51.
        View in: PubMed
      65. Ikuta T, Papayannopoulou T, Stamatoyannopoulos G, Kan YW. Globin gene switching. In vivo protein-DNA interactions of the human beta-globin locus in erythroid cells expressing the fetal or the adult globin gene program. J Biol Chem. 1996 Jun 14; 271(24):14082-91.
        View in: PubMed
      66. Su H, Chang JC, Xu SM, Kan YW. Selective killing of AFP-positive hepatocellular carcinoma cells by adeno-associated virus transfer of the herpes simplex virus thymidine kinase gene. Hum Gene Ther. 1996 Mar 1; 7(4):463-70.
        View in: PubMed
      67. Teitz T, Chang JC, Kan YW, Yen TS. Thymic epithelial neoplasms in transgenic mice expressing SV40 T antigen under the control of an erythroid-specific enhancer. J Pathol. 1995 Nov; 177(3):309-15.
        View in: PubMed
      68. Han X, Kasahara N, Kan YW. Ligand-directed retroviral targeting of human breast cancer cells. Proc Natl Acad Sci U S A. 1995 Oct 10; 92(21):9747-51.
        View in: PubMed
      69. Pischedda C, Cocco S, Melis A, Marini MG, Kan YW, Cao A, Moi P. Isolation of a differentially regulated splicing isoform of human NF-E2. Proc Natl Acad Sci U S A. 1995 Apr 11; 92(8):3511-5.
        View in: PubMed
      70. Chan JY, Cheung MC, Moi P, Chan K, Kan YW. Chromosomal localization of the human NF-E2 family of bZIP transcription factors by fluorescence in situ hybridization. Hum Genet. 1995 Mar; 95(3):265-9.
        View in: PubMed
      71. Kasahara N, Dozy AM, Kan YW. Tissue-specific targeting of retroviral vectors through ligand-receptor interactions. Science. 1994 Nov 25; 266(5189):1373-6.
        View in: PubMed
      72. Moi P, Chan K, Asunis I, Cao A, Kan YW. Isolation of NF-E2-related factor 2 (Nrf2), a NF-E2-like basic leucine zipper transcriptional activator that binds to the tandem NF-E2/AP1 repeat of the beta-globin locus control region. Proc Natl Acad Sci U S A. 1994 Oct 11; 91(21):9926-30.
        View in: PubMed
      73. Teitz T, Yen TS, Kan YW. Amplification of a SV40 T antigen transgene is associated with sarcomagenesis in mice. Carcinogenesis. 1994 Sep; 15(9):2049-51.
        View in: PubMed
      74. Teitz T, Yen TS, Chang JC, Kan YW. SV40 T antigen directed by a powerful erythroid enhancer-promoter produced sarcomas and pancreatic tumors but not erythroid-specific tumors in transgenic mice. DNA Cell Biol. 1994 Jul; 13(7):705-10.
        View in: PubMed
      75. Dozy AM, Kan YW. Characterization of beta-thalassemia mutations by denaturing gradient gel electrophoresis: patterns in the Mediterranean mutations. Clin Genet. 1994 May; 45(5):221-7.
        View in: PubMed
      76. Cai SP, Wall J, Kan YW, Chehab FF. Reverse dot blot probes for the screening of beta-thalassemia mutations in Asians and American blacks. Hum Mutat. 1994; 3(1):59-63.
        View in: PubMed
      77. Chan JY, Han XL, Kan YW. Cloning of Nrf1, an NF-E2-related transcription factor, by genetic selection in yeast. Proc Natl Acad Sci U S A. 1993 Dec 1; 90(23):11371-5.
        View in: PubMed
      78. Gaensler KM, Kitamura M, Kan YW. Germ-line transmission and developmental regulation of a 150-kb yeast artificial chromosome containing the human beta-globin locus in transgenic mice. Proc Natl Acad Sci U S A. 1993 Dec 1; 90(23):11381-5.
        View in: PubMed
      79. Chan JY, Han XL, Kan YW. Isolation of cDNA encoding the human NF-E2 protein. Proc Natl Acad Sci U S A. 1993 Dec 1; 90(23):11366-70.
        View in: PubMed
      80. Teitz T, Chang JC, Kitamura M, Yen TS, Kan YW. Rhabdomyosarcoma arising in transgenic mice harboring the beta-globin locus control region fused with simian virus 40 large T antigen gene. Proc Natl Acad Sci U S A. 1993 Apr 1; 90(7):2910-4.
        View in: PubMed
      81. Maggio A, Giambona A, Cai SP, Wall J, Kan YW, Chehab FF. Rapid and simultaneous typing of hemoglobin S, hemoglobin C, and seven Mediterranean beta-thalassemia mutations by covalent reverse dot-blot analysis: application to prenatal diagnosis in Sicily. Blood. 1993 Jan 1; 81(1):239-42.
        View in: PubMed
      82. Chasis JA, Coulombel L, Conboy J, McGee S, Andrews K, Kan YW, Mohandas N. Differentiation-associated switches in protein 4.1 expression. Synthesis of multiple structural isoforms during normal human erythropoiesis. J Clin Invest. 1993 Jan; 91(1):329-38.
        View in: PubMed
      83. Conboy JG, Chasis JA, Winardi R, Tchernia G, Kan YW, Mohandas N. An isoform-specific mutation in the protein 4.1 gene results in hereditary elliptocytosis and complete deficiency of protein 4.1 in erythrocytes but not in nonerythroid cells. J Clin Invest. 1993 Jan; 91(1):77-82.
        View in: PubMed
      84. Liu D, Chang JC, Moi P, Liu W, Kan YW, Curtin PT. Dissection of the enhancer activity of beta-globin 5' DNase I-hypersensitive site 2 in transgenic mice. Proc Natl Acad Sci U S A. 1992 May 1; 89(9):3899-903.
        View in: PubMed
      85. Chang JC, Liu D, Kan YW. A 36-base-pair core sequence of locus control region enhances retrovirally transferred human beta-globin gene expression. Proc Natl Acad Sci U S A. 1992 Apr 1; 89(7):3107-10.
        View in: PubMed
      86. Kan YW. Development of DNA analysis for human diseases. Sickle cell anemia and thalassemia as a paradigm. JAMA. 1992 Mar 18; 267(11):1532-6.
        View in: PubMed
      87. Shannon KM, Watterson J, Johnson P, O'Connell P, Lange B, Shah N, Steinherz P, Kan YW, Priest JR. Monosomy 7 myeloproliferative disease in children with neurofibromatosis, type 1: epidemiology and molecular analysis. Blood. 1992 Mar 1; 79(5):1311-8.
        View in: PubMed
      88. Rosatelli MC, Dozy A, Faà V, Meloni A, Sardu R, Saba L, Kan YW, Cao A. Molecular characterization of beta-thalassemia in the Sardinian population. Am J Hum Genet. 1992 Feb; 50(2):422-6.
        View in: PubMed
      89. Chehab FF, Wall J, Kan YW. Amplification and detection of specific DNA sequences with fluorescent PCR primers: application to delta F508 mutation in cystic fibrosis. Methods Enzymol. 1992; 216:135-43.
        View in: PubMed
      90. Ikuta T, Kan YW. In vivo protein-DNA interactions at the beta-globin gene locus. Proc Natl Acad Sci U S A. 1991 Nov 15; 88(22):10188-92.
        View in: PubMed
      91. Cai SP, Eng B, Kan YW, Chui DH. A rapid and simple electrophoretic method for the detection of mutations involving small insertion or deletion: application to beta-thalassemia. Hum Genet. 1991 Oct; 87(6):728-30.
        View in: PubMed
      92. Conboy JG, Chan JY, Chasis JA, Kan YW, Mohandas N. Tissue- and development-specific alternative RNA splicing regulates expression of multiple isoforms of erythroid membrane protein 4.1. J Biol Chem. 1991 May 5; 266(13):8273-80.
        View in: PubMed
      93. Chang S, Reid ME, Conboy J, Kan YW, Mohandas N. Molecular characterization of erythrocyte glycophorin C variants. Blood. 1991 Feb 1; 77(3):644-8.
        View in: PubMed
      94. Kan YW. Molecular biology of hemoglobin: its application to sickle cell anemia and thalassemia. Schweiz Med Wochenschr Suppl. 1991; 43:51-4.
        View in: PubMed
      95. Yang-Feng TL, Teitz T, Cheung MC, Kan YW, Canaani D. Assignment of the human casein kinase II beta-subunit gene to 6p12----p21. Genomics. 1990 Dec; 8(4):741-2.
        View in: PubMed
      96. Moi P, Kan YW. Synergistic enhancement of globin gene expression by activator protein-1-like proteins. Proc Natl Acad Sci U S A. 1990 Nov; 87(22):9000-4.
        View in: PubMed
      97. Conboy J, Marchesi S, Kim R, Agre P, Kan YW, Mohandas N. Molecular analysis of insertion/deletion mutations in protein 4.1 in elliptocytosis. II. Determination of molecular genetic origins of rearrangements. J Clin Invest. 1990 Aug; 86(2):524-30.
        View in: PubMed
      98. Lambert S, Yu H, Prchal JT, Lawler J, Ruff P, Speicher D, Cheung MC, Kan YW, Palek J. cDNA sequence for human erythrocyte ankyrin. Proc Natl Acad Sci U S A. 1990 Mar; 87(5):1730-4.
        View in: PubMed
      99. Cai SP, Kan YW. Identification of the multiple beta-thalassemia mutations by denaturing gradient gel electrophoresis. J Clin Invest. 1990 Feb; 85(2):550-3.
        View in: PubMed
      100. Chehab FF, Kan YW. Detection of sickle cell anaemia mutation by colour DNA amplification. Lancet. 1990 Jan 6; 335(8680):15-7.
        View in: PubMed
      101. Dozy AM, Cai SP, Chehab F, Kan YW. The use of direct gene analysis to define beta-thalassemia. Ann N Y Acad Sci. 1990; 612:22-30.
        View in: PubMed
      102. Perrine SP, Faller DV, Swerdlow P, Miller BA, Bank A, Sytkowski AJ, Reczek J, Rudolph AM, Kan YW. Stopping the biologic clock for globin gene switching. Ann N Y Acad Sci. 1990; 612:134-40.
        View in: PubMed
      103. Zhang JZ, Cai SP, Kan YW. Prenatal diagnosis of thalassemia in south China. Ann N Y Acad Sci. 1990; 612:264-7.
        View in: PubMed
      104. Lie-Injo LE, Cai SP, Wahidijat I, Moeslichan S, Lim ML, Evangelista L, Doherty M, Kan YW. Beta-thalassemia mutations in Indonesia and their linkage to beta haplotypes. Am J Hum Genet. 1989 Dec; 45(6):971-5.
        View in: PubMed
      105. McCormick MK, Shero JH, Cheung MC, Kan YW, Hieter PA, Antonarakis SE. Construction of human chromosome 21-specific yeast artificial chromosomes. Proc Natl Acad Sci U S A. 1989 Dec; 86(24):9991-5.
        View in: PubMed
      106. Chehab FF, Kan YW. Detection of specific DNA sequences by fluorescence amplification: a color complementation assay. Proc Natl Acad Sci U S A. 1989 Dec; 86(23):9178-82.
        View in: PubMed
      107. Curtin PT, Liu DP, Liu W, Chang JC, Kan YW. Human beta-globin gene expression in transgenic mice is enhanced by a distant DNase I hypersensitive site. Proc Natl Acad Sci U S A. 1989 Sep; 86(18):7082-6.
        View in: PubMed
      108. Kanno H, Huang IY, Kan YW, Yoshida A. Two structural genes on different chromosomes are required for encoding the major subunit of human red cell glucose-6-phosphate dehydrogenase. Cell. 1989 Aug 11; 58(3):595-606.
        View in: PubMed
      109. Chehab FF, Winterhalter KH, Kan YW. Characterization of a spontaneous mutation in beta-thalassemia associated with advanced paternal age. Blood. 1989 Aug 1; 74(2):852-4.
        View in: PubMed
      110. Cai SP, Zhang JZ, Doherty M, Kan YW. A new TATA box mutation detected at prenatal diagnosis for beta-thalassemia. Am J Hum Genet. 1989 Jul; 45(1):112-4.
        View in: PubMed
      111. Rubin EM, Andrews KA, Kan YW. Newborn screening by DNA analysis of dried blood spots. Hum Genet. 1989 May; 82(2):134-6.
        View in: PubMed
      112. Chehab FF, Xiao X, Kan YW, Yen TS. Detection of cytomegalovirus infection in paraffin-embedded tissue specimens with the polymerase chain reaction. Mod Pathol. 1989 Mar; 2(2):75-8.
        View in: PubMed
      113. Cai SP, Chang CA, Zhang JZ, Saiki RK, Erlich HA, Kan YW. Rapid prenatal diagnosis of beta thalassemia using DNA amplification and nonradioactive probes. Blood. 1989 Feb; 73(2):372-4.
        View in: PubMed
      114. Curtin PT, Kan YW. The molecular genetics of hemoglobin. Ann N Y Acad Sci. 1989; 565:1-12.
        View in: PubMed
      115. Perrine SP, Miller BA, Papayannopoulou T, Faller DV, Rudolph AM, Vichinsky E, Hurst D, Kan YW. Butyrate analogues modulate globin gene expression in human and ovine erythroid cells. Prog Clin Biol Res. 1989; 316B:341-50.
        View in: PubMed
      116. Perrine SP, Swerdlow P, Faller DV, Qin G, Rudolph AM, Reczek J, Kan YW. Butyric acid modulates developmental globin gene switching in man and sheep. Adv Exp Med Biol. 1989; 271:177-83.
        View in: PubMed
      117. Conboy JG, Chan J, Mohandas N, Kan YW. Multiple protein 4.1 isoforms produced by alternative splicing in human erythroid cells. Proc Natl Acad Sci U S A. 1988 Dec; 85(23):9062-5.
        View in: PubMed
      118. Perrine SP, Rudolph A, Faller DV, Roman C, Cohen RA, Chen SJ, Kan YW. Butyrate infusions in the ovine fetus delay the biologic clock for globin gene switching. Proc Natl Acad Sci U S A. 1988 Nov; 85(22):8540-2.
        View in: PubMed
      119. Chan V, Chan TK, Kan YW, Todd D. A novel beta-thalassemia frameshift mutation (codon 14/15), detectable by direct visualization of abnormal restriction fragment in amplified genomic DNA. Blood. 1988 Oct; 72(4):1420-3.
        View in: PubMed
      120. Kosasih EN, Cai SP, Kan YW, Lie-Injo LE. Hemoglobin constant spring defined by specific oligonucleotide hybridization and hemoglobin D Punjab (beta 121----Gln) in a Batak Indonesian family. Am J Hematol. 1988 Sep; 29(1):22-6.
        View in: PubMed
      121. Rubin EM, Kan YW, Mohandas N. Effect of human beta (s)-globin chains on cellular properties of red cells from beta-thalassemic mice. J Clin Invest. 1988 Sep; 82(3):1129-33.
        View in: PubMed
      122. Shen LP, Liu H, Kan YW, Kam W. 5' nucleotide sequence of a putative human placental alkaline phosphatase-like gene. Nucleic Acids Res. 1988 Jun 24; 16(12):5694.
        View in: PubMed
      123. Cai SP, Zhang JZ, Huang DH, Wang ZX, Kan YW. A simple approach to prenatal diagnosis of beta-thalassemia in a geographic area where multiple mutations occur. Blood. 1988 May; 71(5):1357-60.
        View in: PubMed
      124. Rubin EM, Lu RH, Cooper S, Mohandas N, Kan YW. Introduction and expression of the human Bs-globin gene in transgenic mice. Am J Hum Genet. 1988 Apr; 42(4):585-91.
        View in: PubMed
      125. Curtin PT, Kan YW. The inactive beta globin gene on a gamma delta beta thalassemia chromosome has a normal structure and functions normally in vitro. Blood. 1988 Mar; 71(3):766-70.
        View in: PubMed
      126. Huang SZ, Zeng YT, Law ML, Zhang JZ, Kan YW. Type of beta-thalassemia mutations found in the Chinese identified by synthetic oligonucleotides. Hemoglobin. 1988; 12(5-6):577.
        View in: PubMed
      127. Zhang JZ, Cai SP, He X, Lin HX, Lin HJ, Huang ZG, Chehab FF, Kan YW. Molecular basis of beta thalassemia in south China. Strategy for DNA analysis. Hum Genet. 1988 Jan; 78(1):37-40.
        View in: PubMed
      128. Bray PF, Rosa JP, Johnston GI, Shiu DT, Cook RG, Lau C, Kan YW, McEver RP, Shuman MA. Platelet glycoprotein IIb. Chromosomal localization and tissue expression. J Clin Invest. 1987 Dec; 80(6):1812-7.
        View in: PubMed
      129. Bonifas JM, Morley BJ, Oakey RE, Kan YW, Epstein EH. Cloning of a cDNA for steroid sulfatase: frequent occurrence of gene deletions in patients with recessive X chromosome-linked ichthyosis. Proc Natl Acad Sci U S A. 1987 Dec; 84(24):9248-51.
        View in: PubMed
      130. Prchal JT, Morley BJ, Yoon SH, Coetzer TL, Palek J, Conboy JG, Kan YW. Isolation and characterization of cDNA clones for human erythrocyte beta-spectrin. Proc Natl Acad Sci U S A. 1987 Nov; 84(21):7468-72.
        View in: PubMed
      131. Chehab FF, Kan YW, Law ML, Hartz J, Kao FT, Blostein R. Human placental Na+,K+-ATPase alpha subunit: cDNA cloning, tissue expression, DNA polymorphism, and chromosomal localization. Proc Natl Acad Sci U S A. 1987 Nov; 84(22):7901-5.
        View in: PubMed
      132. Rubin EM, Kan YW. The geneticist's grail. West J Med. 1987 Oct; 147(4):462-3.
        View in: PubMed
      133. Chehab FF, Doherty M, Cai SP, Kan YW, Cooper S, Rubin EM. Detection of sickle cell anaemia and thalassaemias. Nature. 1987 Sep 24-30; 329(6137):293-4.
        View in: PubMed
      134. Chan V, Chan TK, Ghosh A, Wong LC, Ma HK, Kan YW, Todd D. Application of DNA polymorphisms for prenatal diagnosis of beta thalassemia in Chinese. Am J Hematol. 1987 Aug; 25(4):409-15.
        View in: PubMed
      135. Pirastu M, Galanello R, Doherty MA, Tuveri T, Cao A, Kan YW. The same beta-globin gene mutation is present on nine different beta-thalassemia chromosomes in a Sardinian population. Proc Natl Acad Sci U S A. 1987 May; 84(9):2882-5.
        View in: PubMed
      136. Chehab FF, Der Kaloustian V, Khouri FP, Deeb SS, Kan YW. The molecular basis of beta-thalassemia in Lebanon: application to prenatal diagnosis. Blood. 1987 Apr; 69(4):1141-5.
        View in: PubMed
      137. Weisberg LJ, Shiu DT, Greenberg CS, Kan YW, Shuman MA. Localization of the gene for coagulation factor XIII a-chain to chromosome 6 and identification of sites of synthesis. J Clin Invest. 1987 Feb; 79(2):649-52.
        View in: PubMed
      138. Perrine S, Kan YW, Greene MF, Rubin E, Cooper S, Cohen R, Roman C, Rudolph A, Faller DV. Inhibition of fetal globin gene switching in vivo in human and ovine fetuses. Prog Clin Biol Res. 1987; 251:545-54.
        View in: PubMed
      139. Lau YF, Chan KM, Kan YW, Goldberg E. Male-enhanced expression and genetic conservation of a gene isolated with an anti-H-Y antibody. Trans Assoc Am Physicians. 1987; 100:45-53.
        View in: PubMed
      140. Conboy J, Kan YW, Shohet SB, Mohandas N. Molecular cloning of protein 4.1, a major structural element of the human erythrocyte membrane skeleton. Proc Natl Acad Sci U S A. 1986 Dec; 83(24):9512-6.
        View in: PubMed
      141. Conboy J, Mohandas N, Tchernia G, Kan YW. Molecular basis of hereditary elliptocytosis due to protein 4.1 deficiency. N Engl J Med. 1986 Sep 11; 315(11):680-5.
        View in: PubMed
      142. Chan V, Chan TK, Cheng MY, Kan YW, Todd D. Organization of the zeta-alpha genes in Chinese. Br J Haematol. 1986 Sep; 64(1):97-105.
        View in: PubMed
      143. Chan V, Chan TK, Cheng MY, Leung NK, Kan YW, Todd D. Characteristics and distribution of beta thalassemia haplotypes in South China. Hum Genet. 1986 May; 73(1):23-6.
        View in: PubMed
      144. Beaudry MA, Ferguson DJ, Pearse K, Yanofsky RA, Rubin EM, Kan YW. Survival of a hydropic infant with homozygous alpha-thalassemia-1. J Pediatr. 1986 May; 108(5 Pt 1):713-6.
        View in: PubMed
      145. Bray PF, Rosa JP, Lingappa VR, Kan YW, McEver RP, Shuman MA. Biogenesis of the platelet receptor for fibrinogen: evidence for separate precursors for glycoproteins IIb and IIIa. Proc Natl Acad Sci U S A. 1986 Mar; 83(5):1480-4.
        View in: PubMed
      146. Chehab FF, Honig GR, Kan YW. Spontaneous mutation in beta-thalassaemia producing the same nucleotide substitution as that in a common hereditary form. Lancet. 1986 Jan 4; 1(8471):3-5.
        View in: PubMed
      147. Kan YW. The William Allan Memorial Award address: Thalassemia: molecular mechanism and detection. Am J Hum Genet. 1986 Jan; 38(1):4-12.
        View in: PubMed
      148. Prchal JT, Cashman DP, Kan YW. Hemoglobin Long Island is caused by a single mutation (adenine to cytosine) resulting in a failure to cleave amino-terminal methionine. Proc Natl Acad Sci U S A. 1986 Jan; 83(1):24-7.
        View in: PubMed
      149. Choo KH, Filby G, Greco S, Lau YF, Kan YW. Cosmid vectors for high efficiency DNA-mediated transformation and gene amplification in mammalian cells: studies with the human growth hormone gene. Gene. 1986; 46(2-3):277-86.
        View in: PubMed
      150. Lebo RV, Anderson LA, Lau YF, Flandermeyer R, Kan YW. Flow-sorting analysis of normal and abnormal human genomes. Cold Spring Harb Symp Quant Biol. 1986; 51 Pt 1:169-76.
        View in: PubMed
      151. Ho YS, Norton GP, Palese P, Dozy AM, Kan YW. Expression and function of suppressor tRNA genes in mammalian cells. Cold Spring Harb Symp Quant Biol. 1986; 51 Pt 2:1033-40.
        View in: PubMed
      152. Kam W, Clauser E, Kim YS, Kan YW, Rutter WJ. Cloning, sequencing, and chromosomal localization of human term placental alkaline phosphatase cDNA. Proc Natl Acad Sci U S A. 1985 Dec; 82(24):8715-9.
        View in: PubMed
      153. Curtin P, Pirastu M, Kan YW, Gobert-Jones JA, Stephens AD, Lehmann H. A distant gene deletion affects beta-globin gene function in an atypical gamma delta beta-thalassemia. J Clin Invest. 1985 Oct; 76(4):1554-8.
        View in: PubMed
      154. Lebo RV, Tolan DR, Bruce BD, Cheung MC, Kan YW. Spot-blot analysis of sorted chromosomes assigns a fructose intolerance disease locus to chromosome 9. Cytometry. 1985 Sep; 6(5):478-83.
        View in: PubMed
      155. Chan V, Chan TK, Liang ST, Ghosh A, Kan YW, Todd D. Hydrops fetalis due to an unusual form of Hb H disease. Blood. 1985 Jul; 66(1):224-8.
        View in: PubMed
      156. Ebina Y, Ellis L, Jarnagin K, Edery M, Graf L, Clauser E, Ou JH, Masiarz F, Kan YW, Goldfine ID, et al. The human insulin receptor cDNA: the structural basis for hormone-activated transmembrane signalling. Cell. 1985 Apr; 40(4):747-58.
        View in: PubMed
      157. Del Senno L, Pirastu M, Barbieri R, Bernardi F, Buzzoni D, Marchetti G, Perrotta C, Vullo C, Kan YW, Conconi F. beta (+)-Thalassaemia in the Po river delta region (northern Italy): genotype and beta globin synthesis. J Med Genet. 1985 Feb; 22(1):54-8.
        View in: PubMed
      158. Rubin EM, Kan YW. A simple sensitive prenatal test for hydrops fetalis caused by alpha-thalassaemia. Lancet. 1985 Jan 12; 1(8420):75-7.
        View in: PubMed
      159. Lebo RV, Cheung MC, Bruce BD, Riccardi VM, Kao FT, Kan YW. Mapping parathyroid hormone, beta-globin, insulin, and LDH-A genes within the human chromosome 11 short arm by spot blotting sorted chromosomes. Hum Genet. 1985; 69(4):316-20.
        View in: PubMed
      160. Lebo RV, Kan YW, Cheung MC, Jain SK, Drysdale J. Human ferritin light chain gene sequences mapped to several sorted chromosomes. Hum Genet. 1985; 71(4):325-8.
        View in: PubMed
      161. Kan YW. Molecular pathology of alpha-thalassemia. Ann N Y Acad Sci. 1985; 445:28-36.
        View in: PubMed
      162. Pirastu M, Saglio G, Chang JC, Cao A, Kan YW. Initiation codon mutation as a cause of alpha thalassemia. J Biol Chem. 1984 Oct 25; 259(20):12315-7.
        View in: PubMed
      163. Chan V, Leung NK, Chan TK, Ghosh A, Kan YW, Todd D. BamH I polymorphism in the Chinese: its potential usefulness in prenatal diagnosis of beta thalassaemia. Br Med J (Clin Res Ed). 1984 Oct 13; 289(6450):947-8.
        View in: PubMed
      164. Lau YF, Lin CC, Kan YW. Amplification and expression of human alpha-globin genes in Chinese hamster ovary cells. Mol Cell Biol. 1984 Aug; 4(8):1469-75.
        View in: PubMed
      165. Lebo RV, Gorin F, Fletterick RJ, Kao FT, Cheung MC, Bruce BD, Kan YW. High-resolution chromosome sorting and DNA spot-blot analysis assign McArdle's syndrome to chromosome 11. Science. 1984 Jul 6; 225(4657):57-9.
        View in: PubMed
      166. Pirastu M, Kan YW, Galanello R, Cao A. Multiple mutations produce delta beta 0 thalassemia in Sardinia. Science. 1984 Mar 2; 223(4639):929-30.
        View in: PubMed
      167. Lau YF, Huang JC, Dozy AM, Kan YW. A rapid screening test for antenatal sex determination. Lancet. 1984 Jan 7; 1(8367):14-6.
        View in: PubMed
      168. Lau YF, Kan YW. Direct isolation of the functional human thymidine kinase gene with a cosmid shuttle vector. Proc Natl Acad Sci U S A. 1984 Jan; 81(2):414-8.
        View in: PubMed
      169. Pirastu M, del Senno L, Conconi F, Vullo C, Kan YW. Ferrara beta 0 thalassaemia caused by the beta 39 nonsense mutation. Nature. 1984 Jan 5-11; 307(5946):76.
        View in: PubMed
      170. Chang JC, Alberti A, Kan YW. A beta-thalassemia lesion abolishes the same Mst II site as the sickle mutation. Nucleic Acids Res. 1983 Nov 25; 11(22):7789-94.
        View in: PubMed
      171. Lau YF, Kan YW. Versatile cosmid vectors for the isolation, expression, and rescue of gene sequences: studies with the human alpha-globin gene cluster. Proc Natl Acad Sci U S A. 1983 Sep; 80(17):5225-9.
        View in: PubMed
      172. Pirastu M, Kan YW, Cao A, Conner BJ, Teplitz RL, Wallace RB. Prenatal diagnosis of beta-thalassemia. Detection of a single nucleotide mutation in DNA. N Engl J Med. 1983 Aug 4; 309(5):284-7.
        View in: PubMed
      173. Pirastu M, Kan YW, Lin CC, Baine RM, Holbrook CT. Hemolytic disease of the newborn caused by a new deletion of the entire beta-globin cluster. J Clin Invest. 1983 Aug; 72(2):602-9.
        View in: PubMed
      174. Pirastu M, Galanello R, Melis MA, Brancati C, Tagarelli A, Cao A, Kan YW. Delta +-thalassemia in Sardinia. Blood. 1983 Aug; 62(2):341-5.
        View in: PubMed
      175. Liebhaber SA, Kan YW. alpha-Thalassemia caused by an unstable alpha-globin mutant. J Clin Invest. 1983 Mar; 71(3):461-6.
        View in: PubMed
      176. Lau YF, Lin CC, Kan YW. Amplification of the human alpha-globin gene enhances its expression. Trans Assoc Am Physicians. 1983; 96:93-102.
        View in: PubMed
      177. Kan YW. Thalassemia and abnormal hemoglobins. Haematologia (Budap). 1982 Dec; 15(4):351-4.
        View in: PubMed
      178. Liebhaber SA, Kan YW. Different rates of mRNA translation balance the expression of the two human alpha-globin loci. J Biol Chem. 1982 Oct 25; 257(20):11852-5.
        View in: PubMed
      179. Pirastu M, Lee KY, Dozy AM, Kan YW, Stamatoyannopoulos G, Hadjiminas MG, Zachariades Z, Angius A, Furbetta M, Rosatelli C, Cao A. Alpha-thalassemia in two Mediterranean populations. Blood. 1982 Aug; 60(2):509-12.
        View in: PubMed
      180. Chang JC, Kan YW. A sensitive new prenatal test for sickle-cell anemia. N Engl J Med. 1982 Jul 1; 307(1):30-2.
        View in: PubMed
      181. Chang JC, Golbus MS, Kan YW. Antenatal diagnosis of sickle cell anemia by sensitive DNA assay. Lancet. 1982 Jun 26; 1(8287):1463.
        View in: PubMed
      182. Shurafa MS, Prasad AS, Rucknagel DL, Kan YW. Long survival in sickle cell anemia. Am J Hematol. 1982 Jun; 12(4):357-65.
        View in: PubMed
      183. Goossens M, Lee KY, Liebhaber SA, Kan YW. Globin structural mutant alpha 125Leu leads to Pro is a novel cause of alpha-thalassaemia. Nature. 1982 Apr 29; 296(5860):864-5.
        View in: PubMed
      184. Temple GF, Dozy AM, Roy KL, Kan YW. Construction of a functional human suppressor tRNA gene: an approach to gene therapy for beta-thalassaemia. Nature. 1982 Apr 8; 296(5857):537-40.
        View in: PubMed
      185. Embury SH, Dozy AM, Miller J, Davis JR, Kleman KM, Preisler H, Vichinsky E, Lande WN, Lubin BH, Kan YW, Mentzer WC. Concurrent sickle-cell anemia and alpha-thalassemia: effect on severity of anemia. N Engl J Med. 1982 Feb 4; 306(5):270-4.
        View in: PubMed
      186. Lie-Injo LE, Solai A, Herrera AR, Nicolaisen L, Kan YW, Wan WP, Hasan K. Hb Bart's level in cord blood and deletions of alpha-globin genes. Blood. 1982 Feb; 59(2):370-6.
        View in: PubMed
      187. Steinbrecher UP, Kan YW, de Leeuw NK. Prenatal prediction of alpha-thalassemia phenotype by endonuclease mapping of parental DNA. Can Med Assoc J. 1982 Jan 15; 126(2):156-7.
        View in: PubMed
      188. Kan YW, Chang JC, Dozy AM. Prenatal diagnosis by DNA analysis. Birth Defects Orig Artic Ser. 1982; 18(7):275-83.
        View in: PubMed
      189. Lebo RV, Kan YW, Cheung MC, Carrano AV, Yu LC, Chang JC, Cordell B, Goodman HM. Assigning the polymorphic human insulin gene to the short arm of chromosome 11 by chromosome sorting. Hum Genet. 1982; 60(1):10-15.
        View in: PubMed
      190. Chang JC, Kan YW. A sensitive test for prenatal diagnosis of sickle cell anemia: direct analysis of amniocyte DNA with MstII. Trans Assoc Am Physicians. 1982; 95:71-8.
        View in: PubMed
      191. Liebhaber SA, Kan YW. Molecular pathology of alpha-thalassemia. Birth Defects Orig Artic Ser. 1982; 18(7):35-44.
        View in: PubMed
      192. Pergolizzi R, Spritz RA, Spence S, Goossens M, Kan YW, Bank A. Two cloned beta thalassemia genes are associated with amber mutations at codon 39. Nucleic Acids Res. 1981 Dec 21; 9(24):7065-72.
        View in: PubMed
      193. Chang JC, Kan YW. Antenatal diagnosis of sickle cell anaemia by direct analysis of the sickle mutation. Lancet. 1981 Nov 21; 2(8256):1127-9.
        View in: PubMed
      194. Trecartin RF, Liebhaber SA, Chang JC, Lee KY, Kan YW, Furbetta M, Angius A, Cao A. beta zero thalassemia in Sardinia is caused by a nonsense mutation. J Clin Invest. 1981 Oct; 68(4):1012-7.
        View in: PubMed
      195. Martin SL, Zimmer EA, Davidson WS, Wilson AC, Kan YW. The untranslated regions of beta-globin mRNA evolve at a functional rate in higher primates. Cell. 1981 Sep; 25(3):737-41.
        View in: PubMed
      196. Lie-Injo LE, Herrera AR, Kan YW. Two types of triplicated alpha-globin loci in humans. Nucleic Acids Res. 1981 Aug 11; 9(15):3707-17.
        View in: PubMed
      197. Liebhaber SA, Kan YW. Differentiation of the mRNA transcripts originating from the alpha 1- and alpha 2-globin loci in normals and alpha-thalassemics. J Clin Invest. 1981 Aug; 68(2):439-46.
        View in: PubMed
      198. Liebhaber SA, Goossens M, Kan YW. Homology and concerted evolution at the alpha 1 and alpha 2 loci of human alpha-globin. Nature. 1981 Mar 5; 290(5801):26-9.
        View in: PubMed
      199. Goossens M, Lee KY, Dozy AM, Saint Martin C, Monplaisir N, Seytor S, Yoyo M, Dubart A, Rosa J, Kan YW. [Antenatal diagnosis of sickle-cell anaemia by DNA analysis of amniotic fluid cells. A preliminary study in the French West-Indies (author's transl)]. Nouv Presse Med. 1981 Feb 14; 10(6):387-9.
        View in: PubMed
      200. Liebhaber SA, Trecartin RF, Kan YW. Beta thalassemia in Sardinia in the result of a nonsense mutation. Trans Assoc Am Physicians. 1981; 94:88-96.
        View in: PubMed
      201. Embury SH, Miller JA, Dozy AM, Kan YW, Chan V, Todd D. Two different molecular organizations account for the single alpha-globin gene of the alpha-thalassemia-2 genotype. J Clin Invest. 1980 Dec; 66(6):1319-25.
        View in: PubMed
      202. Liebhaber SA, Goossens MJ, Kan YW. Cloning and complete nucleotide sequence of human 5'-alpha-globin gene. Proc Natl Acad Sci U S A. 1980 Dec; 77(12):7054-8.
        View in: PubMed
      203. Todd D, Chan V, Schneider RG, Dozy AM, Kan YW, Chan TK. Globin chain synthesis in haemoglobin New York (beta 113 replaced by glutamic acid). Br J Haematol. 1980 Dec; 46(4):557-64.
        View in: PubMed
      204. Farquhar MN, Papayannopoulou T, Brice M, Kan YW, Stamatoyannopoulos G. Cellular regulation of fetal hemoglobin synthesis in man. Investigation of gamma and beta mRNA accumulation in clonal erythroid cultures initiated from erythroid progenitors derived from fetuses, neonates, and adult individuals. Dev Biol. 1980 Nov; 80(1):64-78.
        View in: PubMed
      205. Kan YW, Dozy AM. Evolution of the hemoglobin S and C genes in world populations. Science. 1980 Jul 18; 209(4454):388-91.
        View in: PubMed
      206. Deisseroth A, Bode U, Lebo R, Dozy A, Kan YW. Isolation of hybrid cell clones that contain deletion and non-deletion defects of alpha-thalassemia in man. Blood. 1980 Jun; 55(6):992-6.
        View in: PubMed
      207. Martin SL, Zimmer EA, Kan YW, Wilson AC. Silent delta-globin gene in Old World monkeys. Proc Natl Acad Sci U S A. 1980 Jun; 77(6):3563-6.
        View in: PubMed
      208. Brittenham G, Lozoff B, Harris JW, Kan YW, Dozy AM, Nayudu NV. Alpha globin gene number: population and restriction endonuclease studies. Blood. 1980 Apr; 55(4):706-8.
        View in: PubMed
      209. Zimmer EA, Martin SL, Beverley SM, Kan YW, Wilson AC. Rapid duplication and loss of genes coding for the alpha chains of hemoglobin. Proc Natl Acad Sci U S A. 1980 Apr; 77(4):2158-62.
        View in: PubMed
      210. Kan YW, Lee KY, Furbetta M, Angius A, Cao A. Polymorphism of DNA sequence in the beta-globin gene region. Application to prenatal diagnosis of beta 0 thalassemia in Sardinia. N Engl J Med. 1980 Jan 24; 302(4):185-8.
        View in: PubMed
      211. Goossens M, Dozy AM, Embury SH, Zachariades Z, Hadjiminas MG, Stamatoyannopoulos G, Kan YW. Triplicated alpha-globin loci in humans. Proc Natl Acad Sci U S A. 1980 Jan; 77(1):518-21.
        View in: PubMed
      212. Kan YW. Hemoglobin abnormalities: molecular and evolutionary studies. Harvey Lect. 1980-1981; 76:75-93.
        View in: PubMed
      213. Kan YW, Trecartin RF, Dozy AM. Prenatal diagnosis of hemoglobinopathies. Ann N Y Acad Sci. 1980; 344:141-50.
        View in: PubMed
      214. Embury SH, Dozy AM, Kan YW. Molecular mechanisms in alpha thalassemia: racial differences in alpha-globin gene organization. Ann N Y Acad Sci. 1980; 344:31-40.
        View in: PubMed
      215. Chang JC, Kan YW, Trecartin RF, Temple GF. Nonsense mutation as a cause of beta 0 thalassemia. Ann N Y Acad Sci. 1980; 344:113-9.
        View in: PubMed
      216. Lie-Injo LE, Dozy AM, Kan YW, Lopes M, Todd D. The alpha-globin gene adjacent to the gene for HbQ-alpha 74 Asp replaced by His is deleted, but not that adjacent to the gene for HbG-alpha 30 Glu replaced by Gln; three-fourths of the alpha-globin genes are deleted in HbQ-alpha-thalassemia. Blood. 1979 Dec; 54(6):1407-16.
        View in: PubMed
      217. Kan YW, Dozy AM, Stamatoyannopoulos G, Hadjiminas MG, Zachariades Z, Furbetta M, Cao A. Molecular basis of hemoglobin-H disease in the Mediterranean population. Blood. 1979 Dec; 54(6):1434-8.
        View in: PubMed
      218. Lebo RV, Carrano AV, Burkhart-Schultz K, Dozy AM, Yu LC, Kan YW. Assignment of human beta-, gamma-, and delta-globin genes to the short arm of chromosome 11 by chromosome sorting and DNA restriction enzyme analysis. Proc Natl Acad Sci U S A. 1979 Nov; 76(11):5804-8.
        View in: PubMed
      219. Chang JC, Temple GF, Trecartin RF, Kan YW. Suppression of the nonsense mutation in homozygous beta 0 thalassaemia. Nature. 1979 Oct 18; 281(5732):602-3.
        View in: PubMed
      220. Matthay KK, Mentzer WC, Dozy AM, Kan YW, Bainton DF. Modification of hemoglobin H disease by sickle trait. J Clin Invest. 1979 Oct; 64(4):1024-32.
        View in: PubMed
      221. Davis JR, Dozy AM, Lubin B, Koenig HM, Pierce HI, Stamatoyannopoulos G, Kan YW. Alpha-thalassemia in blacks is due to gene deletion. Am J Hum Genet. 1979 Sep; 31(5):569-73.
        View in: PubMed
      222. Dozy AM, Kan YW, Embury SH, Mentzer WC, Wang WC, Lubin B, Davis JR, Koenig HM. alpha-Globin gene organisation in blacks precludes the severe form of alpha-thalassaemia. Nature. 1979 Aug 16; 280(5723):605-7.
        View in: PubMed
      223. Chang JC, Kan YW. beta 0 thalassemia, a nonsense mutation in man. Proc Natl Acad Sci U S A. 1979 Jun; 76(6):2886-9.
        View in: PubMed
      224. Embury SH, Lebo RV, Dozy AM, Kan YW. Organization of the alpha-globin genes in the Chinese alpha-thalassemia syndromes. J Clin Invest. 1979 Jun; 63(6):1307-10.
        View in: PubMed
      225. Dozy AM, Forman EN, Abuelo DN, Barsel-Bowers G, Mahoney MJ, Forget BG, Kan YW. Prenatal diagnosis of homozygous alpha-thalassemia. JAMA. 1979 Apr 13; 241(15):1610-2.
        View in: PubMed
      226. Dozy AM, Embury SH, Kan YW. The frequent occurrence of alpha thalassemia in blacks. Trans Assoc Am Physicians. 1979; 92:96-103.
        View in: PubMed
      227. Poon R, Kan YW, Boyer HW. Sequence of the 3'-noncoding and adjacent coding regions of human gamma-globin mRNA. Nucleic Acids Res. 1978 Dec; 5(12):4625-30.
        View in: PubMed
      228. Kan YW, Dozy AM. Polymorphism of DNA sequence adjacent to human beta-globin structural gene: relationship to sickle mutation. Proc Natl Acad Sci U S A. 1978 Nov; 75(11):5631-5.
        View in: PubMed
      229. Kan YW, Dozy AM. Antenatal diagnosis of sickle-cell anaemia by D.N.A. analysis of amniotic-fluid cells. Lancet. 1978 Oct 28; 2(8096):910-2.
        View in: PubMed
      230. Chang JC, Poon R, Neumann KH, Kan YW. The nucleotide sequence of the 5' untranslated region of human gamma-globin mRNA. Nucleic Acids Res. 1978 Oct; 5(10):3515-22.
        View in: PubMed
      231. Wong V, Ma HK, Todd D, Golbus MS, Dozy AM, Kan YW. Diagnosis of homozygous alpha-thalassemia in cultured amniotic-fluid fibroblasts. N Engl J Med. 1978 Mar 23; 298(12):669-70.
        View in: PubMed
      232. Koenig HM, Vedvick TS, Dozy AM, Golbus MS, Kan YW. Prenatal diagnosis of hemoglobin H disease. J Pediatr. 1978 Feb; 92(2):278-81.
        View in: PubMed
      233. Kan YW, Dozy AM, Trecartin R, Todd D. Identification of a nondeletion defect in alpha-thalassemia. N Engl J Med. 1977 Nov 17; 297(20):1081-4.
        View in: PubMed
      234. Chang JC, Temple GF, Poon R, Neumann KH, Kan YW. The nucleotide sequences of the untranslated 5' regions of human alpha- and beta-globin mRNAs. Proc Natl Acad Sci U S A. 1977 Nov; 74(11):5145-9.
        View in: PubMed
      235. Temple GF, Chang JC, Kan YW. Authentic beta-globin mRNA sequences in homozygous betaO-thalassemia. Proc Natl Acad Sci U S A. 1977 Jul; 74(7):3047-51.
        View in: PubMed
      236. Kan YW, Trecartin RF, Golbus MS, Filly RA. Prenatal diagnosis of beta-thalassaemia and sickle-cell anaemia. Experience with 24 cases. Lancet. 1977 Feb 5; 1(8006):269-71.
        View in: PubMed
      237. Kan YW. Prenatal diagnosis of hemoglobin disorders. Prog Hematol. 1977; 10:91-104.
        View in: PubMed
      238. Dozy AM, Kabisch H, Baker J, Koenig HM, Kurachi S, Stamatoyannopoulos G, Todd D, Kan YW. The molecular defects of alpha-thalassemia in the Filipino. Hemoglobin. 1977; 1(6):539-46.
        View in: PubMed
      239. Kan YW, Golbus MS, Dozy AM. Prenatal diagnosis of alpha-thalassemia. Clinical application of molecular hybridization. N Engl J Med. 1976 Nov 18; 295(21):1165-7.
        View in: PubMed
      240. Kan YW, Golbus MS, Trecartin R. Prenatal diagnosis of sickle-cell anemia. N Engl J Med. 1976 May 6; 294(19):1039-40.
        View in: PubMed
      241. Golbus MS, Kan YW, Naglich-Craig M. Fetal blood sampling in midtrimester pregnancies. Am J Obstet Gynecol. 1976 Mar 15; 124(6):653-5.
        View in: PubMed
      242. Kan YW, Holland JP, Dozy AM, Varmus HE. Demonstration of non-functional beta-globin mRNA in homozygous beta (0) thalassemia. Proc Natl Acad Sci U S A. 1975 Dec; 72(12):5140-4.
        View in: PubMed
      243. Kan YW, Holland JP, Dozy AM, Charache S, Kazazian HH. Deletion of the beta-globin structure gene in hereditary persistence of foetal haemoglobin. Nature. 1975 Nov 13; 258(5531):162-3.
        View in: PubMed
      244. Kan YW, Golbus MS, Trecartin R. Prenatal diagnosis of homozygous beta-thalassaemia. Lancet. 1975 Oct 25; 2(7939):790-1.
        View in: PubMed
      245. Kan YW, Golbus MS, Klein P, Dozy AM. Successful application of prenatal diagnosis in a pregnancy at risk for homozygous beta-thalassemia. N Engl J Med. 1975 May 22; 292(21):1096-9.
        View in: PubMed
      246. Kan YW, Dozy AM, Varmus HE, Taylor JM, Holland JP, Lie-Injo LE, Ganesan J, Todd D. Deletion of alpha-globin genes in haemoglobin-H disease demonstrates multiple alpha-globin structural loci. Nature. 1975 May 15; 255(5505):255-6.
        View in: PubMed
      247. Taylor JM, Dozy A, Kan YW, Varmus HE, Lie-Injo LE, Ganesan J, Todd D. Genetic lesion in homozygous alpha thalassaemia (hydrops fetalis). Nature. 1974 Oct 4; 251(5474):392-3.
        View in: PubMed
      248. Kan YW, Todd D, Dozy AM. Haemoglobin Constant Spring synthesis in red cell precursors. Br J Haematol. 1974 Sep; 28(1):103-7.
        View in: PubMed
      249. Chang H, Hobbins JC, Cividalli G, Frigoletto FD, Mahoney MJ, Kan YW, Nathan DG. In utero diagnosis of: hemoglobinopathies. Hemoglobin synthesis in fetal red cells. N Engl J Med. 1974 May 9; 290(19):1067-8.
        View in: PubMed
      250. Cividalli G, Nathan DG, Kan YW, Santamarina B, Frigoletto F. Relation of beta to gamma synthesis during the first trimester: an approach to prenatal diagnosis of thalassemia. Pediatr Res. 1974 May; 8(5):553-60.
        View in: PubMed
      251. Kan Y, Nathan DG, Cividalli G, Crookston MC. Concentration of fetal red blood cells from a mixture of maternal and fetal blood by anti-i serum--an aid to prenatal diagnosis of hemoglobinopathies. Blood. 1974 Mar; 43(3):411-5.
        View in: PubMed
      252. Kan YW, Valenti C, Carnazza V, Guidotti R, Rieder RF. Fetal blood-sampling in utero. Lancet. 1974 Jan 19; 1(7847):79-80.
        View in: PubMed
      253. Kan YW, Nathan DG, Cividalii G, Frigoletto F. Intrauterine diagnosis of thalassemia. Ann N Y Acad Sci. 1974; 232(0):145-51.
        View in: PubMed
      254. Alter BP, Kan YW, Nathan DG. Inhibition of hemoglobin synthesis by cyanate in vitro. Blood. 1974 Jan; 43(1):57-68.
        View in: PubMed
      255. Jensen M, Bunn HF, Halikas G, Kan YW, Nathan DG. Effects of cyanate and 2,3-diphosphoglycerate on sickling. Relationship to oxygenation. J Clin Invest. 1973 Oct; 52(10):2542-7.
        View in: PubMed
      256. Alter BP, Kan YW, Nathan DG. Reticulocyte survival in sickle cell anemia: effect of cyanate. Blood. 1972 Nov; 40(5):733-9.
        View in: PubMed
      257. Kan YW, Dozy AM, Alter BP, Frigoletto FD, Nathan DG. Detection of the sickle gene in the human fetus. Potential for intrauterine diagnosis of sickle-cell anemia. N Engl J Med. 1972 Jul 6; 287(1):1-5.
        View in: PubMed
      258. Kan YW, Nathan DG, Lodish HF. Equal synthesis of - and -globin chains in erythroid precursors in heterozygous -thalassemia. J Clin Invest. 1972 Jul; 51(7):1906-9.
        View in: PubMed
      259. Kan YW, Forget BG, Nathan DG. Gamma-beta thalassemia: a cause of hemolytic disease of the newborn. N Engl J Med. 1972 Jan 20; 286(3):129-34.
        View in: PubMed
      260. Nathan DG, Lodish HF, Kan YW, Housman D. Beta thalassemia and translation of globin messenger RNA. Proc Natl Acad Sci U S A. 1971 Oct; 68(10):2514-8.
        View in: PubMed
      261. Kan YW, Nathan DG. Mild thalassemia: the result of interactions of alpha and beta thalassemia genes. J Clin Invest. 1970 Apr; 49(4):635-42.
        View in: PubMed
      262. Schwartz E, Kan YW, Nathan DG. Unbalanced globin chain synthesis in alpha-thalassemia heterozygotes. Ann N Y Acad Sci. 1969 Nov 20; 165(1):288-94.
        View in: PubMed
      263. Kan YW, Schwartz E, Nathan DG. Globin chain synthesis in the alpha thalassemia syndromes. J Clin Invest. 1969 Nov; 47(11):2512-22.
        View in: PubMed
      Yuet's Networks
      Related Concepts
      Derived automatically from this person's publications.
      _
      Co-Authors
      People in Profiles who have published with this person.
      _
      Related Authors
      People who share related concepts with this person.
      _
      Same Department
      Back to TOP